Disc Medicine (IRON) Operating Expenses (2020 - 2026)
Disc Medicine (IRON) reported Operating Expenses of $69.5 million for Q1 2026, up 74.04% year-over-year from $39.9 million in Q1 2025, and up 3.81% on a QoQ basis from $67.0 million in Q4 2025.
Disc Medicine (IRON) has 7 years of Operating Expenses data on file, last reported at $69.5 million in Q1 2026.
- Quarterly Operating Expenses rose 74.04% year-over-year to $69.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $265.6 million (up 92.18% YoY) and the FY2025 annual result came in at $236.0 million, up 81.95% from the prior year.
- Operating Expenses grew to $69.5 million in Q1 2026 per IRON's latest filing, from $67.0 million in the prior quarter.
- Across five years, Operating Expenses topped out at $69.5 million in Q1 2026 and bottomed at $10.0 million in Q1 2022.
- The 5-year median for Operating Expenses is $30.9 million (2024), against an average of $33.8 million.
- Peak annual rise in Operating Expenses reached 173.9% in 2022, while the deepest fall reached 43.2% in 2022.
- Tracing IRON's Operating Expenses over 5 years: stood at $15.0 million in 2022, then surged by 97.82% to $29.7 million in 2023, then advanced by 16.28% to $34.6 million in 2024, then jumped by 93.84% to $67.0 million in 2025, then increased by 3.81% to $69.5 million in 2026.
- Per Business Quant, the three latest IRON Operating Expenses figures stand at $69.5 million (Q1 2026), $67.0 million (Q4 2025), and $67.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.97 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 4.33 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -138.30 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 15.76 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.85 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.82 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.96 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 898.54 Mn |
| 10 | Disc Medicine | 2.76 Bn | 2.03 Bn | - | 69.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 69.52 Mn |
| Dec 31, 2025 | 66.97 Mn |
| Sep 30, 2025 | 67.70 Mn |
| Jun 30, 2025 | 61.41 Mn |
| Mar 31, 2025 | 39.95 Mn |
| Dec 31, 2024 | 34.55 Mn |
| Sep 30, 2024 | 32.86 Mn |
| Jun 30, 2024 | 30.85 Mn |
| Mar 31, 2024 | 31.46 Mn |
| Dec 31, 2023 | 29.71 Mn |
| Sep 30, 2023 | 18.96 Mn |
| Jun 30, 2023 | 17.33 Mn |
| Mar 31, 2023 | 25.13 Mn |
| Dec 31, 2022 | 15.02 Mn |
| Sep 30, 2022 | 10.48 Mn |
| Jun 30, 2022 | 12.02 Mn |
| Mar 31, 2022 | 9.96 Mn |
| Dec 31, 2021 | -20.33 Mn |
| Sep 30, 2021 | 18.45 Mn |
| Jun 30, 2021 | 16.32 Mn |
| Mar 31, 2021 | 16.49 Mn |
| Dec 31, 2020 | 9.79 Mn |
| Sep 30, 2020 | 7.95 Mn |
| Jun 30, 2020 | 6.67 Mn |
| Mar 31, 2020 | 9.63 Mn |